Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Trevi Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues14.16.1
            Revenue growth130.9% 
Cost of goods sold28.112.2
Gross profit-14.1-6.1
            Gross margin-100.0%-100.0%
General and administrative4.32.1
EBIT-18.4-8.2
            EBIT margin-130.8%-135.1%
Pre-tax income-20.7-12.9
Income taxes-0.10.0
            Tax rate0.6%0.2%
Net income-20.5-12.9
            Net margin-146.0%-211.0%
 
Diluted EPS($58.44)($29.80)
Shares outstanding (diluted)0.40.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy